Ibritumomab tiuxetan (Zevalin)
About This Drug
Ibrutimomab tiuxetan is used to treat cancer. It is a radioactive element used in combination with another agent called rituximab. It is given in the vein (IV).
UPMC Hillman Cancer Center is part of the UPMC family.
As of Wednesday, Feb. 12, it is recommended that patients, visitors, and staff wear a mask when entering UPMC clinical buildings.
Explore this Section
Ibrutimomab tiuxetan is used to treat cancer. It is a radioactive element used in combination with another agent called rituximab. It is given in the vein (IV).